For: | Muenphon K, Limpaiboon T, Jearanaikoon P, Pairojkul C, Sripa B, Bhudhisawasdi V. Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis. World J Gastroenterol 2006; 12(26): 4143-4148 [PMID: 16830362 DOI: 10.3748/wjg.v12.i26.4143] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i26/4143.htm |
Number | Citing Articles |
1 |
Yong Sun, Liangxi Wang, Yifang Zhou, Xuefei Mao, Xiangdong Deng, Andre van Wijnen. Cloning and Characterization of the Human Trefoil Factor 3 Gene Promoter. PLoS ONE 2014; 9(4): e95562 doi: 10.1371/journal.pone.0095562
|
2 |
Christopher D. Briggs, Christopher P. Neal, Christopher D. Mann, William P. Steward, Margaret M. Manson, David P. Berry. Prognostic molecular markers in cholangiocarcinoma: A systematic review. European Journal of Cancer 2009; 45(1): 33 doi: 10.1016/j.ejca.2008.08.024
|
3 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_29-1
|
4 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 549 doi: 10.1007/978-3-319-26956-6_29
|
5 |
Motoko Sasaki, Hiroko Ikeda, Yasuni Nakanuma. Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: Physiological distribution and pathological significance. Progress in Histochemistry and Cytochemistry 2007; 42(2): 61 doi: 10.1016/j.proghi.2007.02.001
|
6 |
Yuko Ishibashi, Hiroshi Ohtsu, Masako Ikemura, Yasuko Kikuchi, Takayoshi Niwa, Kotoe Nishioka, Yoshihiro Uchida, Hirona Miura, Susumu Aikou, Toshiaki Gunji, Nobuyuki Matsuhashi, Yasukazu Ohmoto, Takeshi Sasaki, Yasuyuki Seto, Toshihisa Ogawa, Keiichiro Tada, Sachiyo Nomura. Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-05129-y
|
7 |
Boris R.A. Blechacz, Gregory J. Gores. Molecular Genetics of Liver Neoplasia. 2010; : 75 doi: 10.1007/978-1-4419-6082-5_5
|
8 |
Atsushi Nanashima, Kenichiro Shibata, Toshiyuki Nakayama, Syuichi Tobinaga, Masato Araki, Masaki Kunizaki, Hiroaki Takeshita, Shigekazu Hidaka, Terumitsu Sawai, Takeshi Nagayasu, Tsutomu Tagawa. Relationship Between Microvessel Count and Postoperative Survival in Patients with Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology 2009; 16(8): 2123 doi: 10.1245/s10434-009-0494-5
|
9 |
Apinya Jusakul, Sarinya Kongpetch, Bin Tean Teh. Genetics of Opisthorchis viverrini-related cholangiocarcinoma. Current Opinion in Gastroenterology 2015; 31(3): 258 doi: 10.1097/MOG.0000000000000162
|
10 |
Carsten Kamphues, Nadine Al-Abadi, Angelika Dürr, Roberta Bova, Frederick Klauschen, Albrecht Stenzinger, Marcus Bahra, Hussein Al-Abadi, Peter Neuhaus, Daniel Seehofer. The DNA index is a strong predictive marker in intrahepatic cholangiocarcinoma: the results of a five-year prospective study. Surgery Today 2014; 44(7): 1336 doi: 10.1007/s00595-013-0701-7
|
11 |
Aiping Ding, Wenwen Zhao, Xiaoli Shi, Ruyong Yao, Fang Zhou, Lu Yue, Shihai Liu, Wensheng Qiu, Yves St-Pierre. Impact of NPM, TFF3 and TACC1 on the Prognosis of Patients with Primary Gastric Cancer. PLoS ONE 2013; 8(12): e82136 doi: 10.1371/journal.pone.0082136
|
12 |
Sarinya Kongpetch, Apinya Jusakul, Choon Kiat Ong, Weng Khong Lim, Steven G. Rozen, Patrick Tan, Bin Tean Teh. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways. Best Practice & Research Clinical Gastroenterology 2015; 29(2): 233 doi: 10.1016/j.bpg.2015.02.002
|
13 |
Mark Babyatsky, Jing Lin, Xianyang Yio, Anli Chen, Jie-yu Zhang, Yan Zheng, Christina Twyman, Xiuliang Bao, Myron Schwartz, Swan Thung, J. Lawrence Werther, Steven Itzkowitz. Trefoil factor-3 expression in human colon cancer liver metastasis. Clinical & Experimental Metastasis 2009; 26(2): 143 doi: 10.1007/s10585-008-9224-9
|
14 |
Pattaya Seeree, Phorutai Pearngam, Supeecha Kumkate, Tavan Janvilisri. An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma. International Journal of Genomics 2015; 2015: 1 doi: 10.1155/2015/179528
|
15 |
Takeshi Ito, Mika Sakurai‐Yageta, Akiteru Goto, Chawalit Pairojkul, Puangrat Yongvanit, Yoshinori Murakami. Genomic and transcriptional alterations of cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2014; 21(6): 380 doi: 10.1002/jhbp.67
|
16 |
Min Luo, Yan Lin, Rong Liang, Yongqiang Li, Lianying Ge. Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment. Journal of Inflammation Research 2021; : 4217 doi: 10.2147/JIR.S324336
|